| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.200310-1376OC |
| P698 | PubMed publication ID | 14644933 |
| P50 | author | Robin Taylor | Q103752021 |
| P2093 | author name string | Andrew D Smith | |
| Jan O Cowan | |||
| Pamela Jackson | |||
| Chris McLachlan | |||
| Gabrielle Monti-Sheehan | |||
| Sue Filsell | |||
| P2860 | cites work | Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma | Q24678771 |
| Increased nitric oxide in exhaled air of asthmatic patients | Q34321842 | ||
| The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease | Q34613753 | ||
| Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols | Q35088211 | ||
| Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 | ||
| Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre | Q36121113 | ||
| Mucosal inflammation in asthma | Q37946348 | ||
| Hypertonic saline challenge in an epidemiologic survey of asthma in children | Q40693204 | ||
| Physiologic measures: pulmonary function tests. Asthma outcome | Q40809843 | ||
| Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. | Q41537656 | ||
| Testing airway responsiveness using inhaled methacholine or histamine | Q41688521 | ||
| Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma | Q43570664 | ||
| Airway inflammation is present during clinical remission of atopic asthma. | Q43819606 | ||
| A comparison of the validity of different diagnostic tests in adults with asthma. | Q43955597 | ||
| Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma | Q44357077 | ||
| Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects | Q44430918 | ||
| Evaluation of exhaled nitric oxide in schoolchildren at different exhalation flow rates. | Q51706332 | ||
| Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. | Q51713519 | ||
| Non-eosinophilic cor ticosteroid unresponsive asthma | Q55094026 | ||
| Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC) | Q77199721 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 473-478 | |
| P577 | publication date | 2003-11-25 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | |
| P478 | volume | 169 |
| Q47736603 | A flow- and pressure-controlled offline method of exhaled nitric oxide measurement in children |
| Q34409752 | ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. |
| Q38889263 | Accuracy of FENO for diagnosing asthma: a systematic review. |
| Q42376027 | Accuracy of maximal expiratory flow-volume curve curvilinearity and fractional exhaled nitric oxide for detection of children with atopic asthma |
| Q30470504 | Advances in electronic-nose technologies developed for biomedical applications |
| Q29109861 | Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath |
| Q36080147 | Allergic rhinitis, asthma, airway biology, and chronic obstructive pulmonary disease in AJRCCM in 2004. |
| Q44960159 | Alveolar and airway sites of nitric oxide inflammation in treated asthma |
| Q35534747 | An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications |
| Q38050515 | Application of metabolomics approaches to the study of respiratory diseases |
| Q33321687 | Assessing airway inflammation in clinical practice - experience with spontaneous sputum analysis |
| Q80548599 | Association between exhaled nitric oxide and systemic inflammatory markers |
| Q81450871 | Association between exhaled nitric oxide and systemic inflammatory markers |
| Q35751463 | Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type |
| Q46221607 | Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids |
| Q89218803 | Asthma |
| Q51696286 | Asthma diagnosis in the community--time for a change? |
| Q57673464 | Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide |
| Q57776377 | Au-decorated WO3 cross-linked nanodomes for ultrahigh sensitive and selective sensing of NO2 and C2H5OH |
| Q45066429 | Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age. |
| Q38857008 | Biomarkers Guided Treatment Strategies in Adult Patients with Asthma: Ready for the Clinical Field? |
| Q47742563 | Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease |
| Q37270967 | Biomarkers in airway diseases |
| Q34259716 | Bronchial responsiveness is related to increased exhaled NO (FE(NO)) in non-smokers and decreased FE(NO) in smokers |
| Q50615904 | Can exhaled nitric oxide be a surrogate marker of bronchial hyperresponsiveness to adenosine 5'-monophosphate in steroid-naive asthmatic children? |
| Q45199945 | Childhood wheezing phenotypes and FeNO in atopic children at age 8. |
| Q26771615 | Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma |
| Q26772201 | Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma |
| Q38070209 | Clinical application of exhaled nitric oxide measurement in pediatric lung diseases |
| Q28082277 | Clinical application of exhaled nitric oxide measurements in a korean population |
| Q37983636 | Clinical applications of lung function tests: a revisit |
| Q37030847 | Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient |
| Q38464568 | Comparison of two exhaled nitric oxide analyzers: the NIOX MINO hand-held electrochemical analyzer and the NOA280i stationary chemiluminescence analyzer |
| Q34453095 | Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: A cross-sectional study in bronchial asthma and allergic rhinitis |
| Q30488037 | Cough and its importance in COPD |
| Q43865621 | Determinants of exhaled nitric oxide levels (FeNO) in childhood atopic asthma: evidence for neonatal respiratory distress as a factor associated with low FeNO levels. |
| Q47844959 | Determinants of increased exhaled nitric oxide in patients with suspected asthma |
| Q37140439 | Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added]. |
| Q38770013 | Diagnosis and investigation in the severe asthma clinic. |
| Q56892174 | Diagnosis of asthma in symptomatic children based on measures of lung function: an analysis of data from a population-based birth cohort study |
| Q38706709 | Diagnostic accuracy of fractional exhaled nitric oxide in asthma: a systematic review and meta-analysis of prospective studies |
| Q23922950 | Diagnostic approach in cases with suspected work-related asthma |
| Q35854272 | Diagnostic value and influencing factors of fractional exhaled nitric oxide in suspected asthma patients |
| Q42806543 | Diagnostic value of exhaled nitric oxide in childhood asthma and allergy |
| Q35216472 | Differences in spirometry interpretation algorithms: influence on decision making among primary-care physicians |
| Q33728026 | Does obesity produce a distinct asthma phenotype? |
| Q45951317 | Effect of bronchoconstriction on exhaled nitric oxide levels in healthy and asthmatic children. |
| Q44786833 | Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma |
| Q40288250 | Elevated exhaled nitric oxide in newborns of atopic mothers precedes respiratory symptoms. |
| Q40385750 | Elevated nitric oxide in recurrent vulvovaginal candidiasis - association with clinical findings. |
| Q36285933 | Endothelin-1 in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction |
| Q34088102 | Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients |
| Q50940486 | Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma. |
| Q26779074 | Exhaled NO: Determinants and Clinical Application in Children With Allergic Airway Disease |
| Q61479579 | Exhaled Nitric Oxide in Children: A Noninvasive Marker of Airway Inflammation |
| Q33521525 | Exhaled nitric oxide and airway hyperresponsiveness in workers: a preliminary study in lifeguards |
| Q48958566 | Exhaled nitric oxide as a better diagnostic indicator for evaluating wheeze and airway hyperresponsiveness in preschool children |
| Q84799845 | Exhaled nitric oxide in a Taiwanese population: age and lung function as predicting factors |
| Q34006217 | Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology |
| Q36310751 | Exhaled nitric oxide in paediatric asthma |
| Q37343583 | Exhaled nitric oxide in pediatric asthma |
| Q42141343 | Exhaled nitric oxide in stable chronic obstructive pulmonary disease |
| Q37299822 | Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications |
| Q37705680 | Exhaled nitric oxide in the diagnosis and management of childhood asthma |
| Q39025584 | Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review. |
| Q35564195 | Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests |
| Q24678480 | Exhaled nitric oxide measurements: clinical application and interpretation |
| Q33889107 | Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers |
| Q33610703 | Exhaled nitric oxide, susceptibility and new-onset asthma in the Children's Health Study. |
| Q46496987 | Exhaled nitric oxide: a predictor of steroid response |
| Q36994666 | Exhaled nitric oxide: a test for diagnosis and control of asthma? |
| Q36464120 | Factors attributable to the level of exhaled nitric oxide in asthmatic children |
| Q37289430 | FeNO for detecting lower airway involvement in patients with allergic rhinitis |
| Q39411126 | Fraction of exhaled nitric oxide (FeNO ) norms in healthy North African children 5-16 years old. |
| Q33786695 | Fraction of exhaled nitric oxide (FeNO ) norms in healthy Tunisian adults |
| Q36907967 | Fraction of exhaled nitric oxide measurements in the diagnoses of asthma in elderly patients |
| Q47721169 | Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial |
| Q47766219 | High levels and gender difference of exhaled nitric oxide in Chinese schoolchildren. |
| Q46545879 | High resolution CT and bronchial reversibility test for diagnosing COPD. |
| Q46667941 | IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells |
| Q35005572 | IgE sensitisation in relation to flow-independent nitric oxide exchange parameters |
| Q46900490 | Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure |
| Q43052153 | Increase in exhaled nitric oxide is associated with bronchial hyperresponsiveness among apprentices |
| Q37837908 | Inflammatory markers in childhood asthma |
| Q58376167 | Interest of Exhaled Biomarkers in Occupational Asthma to Latex: A Case Report |
| Q51702947 | Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma. |
| Q43244402 | Is exhaled nitric oxide a useful adjunctive test for assessing asthma? |
| Q30379771 | Love Acoustic Wave-Based Devices and Molecularly-Imprinted Polymers as Versatile Sensors for Electronic Nose or Tongue for Cancer Monitoring. |
| Q26781270 | Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath |
| Q33214422 | Measurement of exhaled nitric oxide in young children during tidal breathing through a facemask |
| Q51539111 | Measurement of exhaled nitric oxide: Comparison of different analysers |
| Q37306913 | Measurements of fractional exhaled nitric oxide in pediatric asthma |
| Q51473688 | Misdiagnosis of asthma in schoolchildren. |
| Q37798033 | Monitoring chronic cough: current and future techniques |
| Q35025262 | New therapies and management strategies in the treatment of asthma: patient-focused developments |
| Q34037524 | Nitric oxide enhances Th9 cell differentiation and airway inflammation |
| Q43265875 | Nitric oxide measurement in chronic cough |
| Q47779700 | Novel hand-held device for exhaled nitric oxide-analysis in research and clinical applications |
| Q37097729 | Partitioned exhaled nitric oxide to non-invasively assess asthma |
| Q33876003 | Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma. |
| Q91810655 | Patterns of bronchial challenge testing in Canada |
| Q92996041 | Performance of Amperometric Platinized-Nafion Based Gas Phase Sensor for Determining Nitric Oxide (NO) Levels in Exhaled Human Nasal Breath |
| Q34619820 | Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children |
| Q57614641 | Personality profiles and pulmonary function of children with sighing dyspnoea |
| Q37890481 | Phenotype-directed treatment of pre-school-aged children with recurrent wheeze. |
| Q40388683 | Race is associated with differences in airway inflammation in patients with asthma |
| Q38125948 | Recent advances in asthma biomarker research. |
| Q34625434 | Reference ranges for exhaled nitric oxide derived from a random community survey of adults |
| Q43589130 | Reference values and determinants of exhaled nitric oxide in healthy Korean adults |
| Q35870842 | Sputum tests in the diagnosis and monitoring of asthma |
| Q34463735 | Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research |
| Q37269755 | Study of the correlations between fractional exhaled nitric oxide in exhaled breath and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children |
| Q40724048 | Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation |
| Q39766125 | The Breathmobile: a novel comprehensive school-based mobile asthma care clinic for urban underprivileged children |
| Q40690044 | The Effect of Viral Infection on Exhaled Nitric Oxide in Children with Acute Asthma Exacerbations |
| Q80945174 | The clinical use of exhaled nitric oxide in wheezing children |
| Q36871653 | The relationship between psychogenic cough and the diagnosis and misdiagnosis of asthma: a review |
| Q48433856 | The role of exhaled nitric oxide and exhaled breath condensates in evaluating airway inflammation in asthma |
| Q37261439 | The use of exhaled nitric oxide in the management of asthma. |
| Q34627601 | The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial |
| Q46642207 | The value of exhaled nitric oxide in predicting bronchial hyperresponsiveness in children |
| Q37979252 | Update on exhaled nitric oxide in pulmonary disease |
| Q33868572 | Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma |
| Q51139521 | Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone. |
| Q44046418 | Usefulness of impulse oscillometry and fractional exhaled nitric oxide in children with Eosinophilic bronchitis. |
| Q37304921 | Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care |
| Q38609780 | Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis. |
| Q57415774 | Will exhaled nitric oxide monitoring become routine in managing asthma? |
| Q83410645 | [ALERTA 2 guidelines. Latin America and Spain: recommendations for the prevention and treatment of asmatic exacerbations. Spanish Pulmonology and Thoracic Surgery Society (SEPAR). Asthma Department of the Latinamerican Thoracic Association (ALAT)] |
| Q80133307 | [Agreement between two devices for measuring exhaled nitric oxide] |
| Q81039567 | [Art--and artefacts--of exhaled NO measurement in asthma] |
| Q52404651 | [Measurement of fraction of exhaled nitric oxide with the portable NIOX-MINO monitor in healthy adults]. |
Search more.